MF Gyan
sectorHigh risk2 year old

Bajaj Finserv Healthcare Fund - Direct Plan - Growth

Invests only in one industry or theme (like banking, pharma, tech). Highly concentrated — bigger swings. From Bajaj Finserv Mutual Fund. It's been running since 30 Dec 2024.

This fund is under 3 years old — its short track record makes comparing to peers or judging consistency less reliable.
Latest price per unit
₹12.135
▼ 0.48% today
As of 4 Sep 2026 · updated once each business day

What ₹1 lakh would have become

Based on past returns
Invested 1 year ago
₹1.22 L
▲ ₹22.0k gain · 22.0% / year

These are calculations from the fund's past prices, not a prediction. Real future returns can and often do differ.

SIP simulator

Play with a monthly investment

Slide the amount and switch the duration. Left column uses real past prices. Right column projects forward using this fund's historical rate — a calculation, not a prediction.

₹5.0k
Looking back · real
You would have invested₹60.0k
Value today₹71.1k
Gain / loss+₹11.1k
XIRR (annualised)42.62%
Looking forward · hypothetical
You would invest₹60.0k
Would become*₹75.8k
Projected gain*+₹15.8k
*at this fund's historical rate of 42.62% per year. Actual future returns can be different — sometimes very different.
Value Cumulative invested
Reality check. The backward SIP is real math on real past NAVs. The forward projection assumes the fund keeps up its historical rate — which rarely happens exactly. Past performance is not a promise. MF Gyan does not recommend any specific investment.
How it compares to peers

Vs 363 other funds in Equity Scheme - Sectoral/ Thematic

Same plan
1-year return
22.00%median 6.47% (+15.53%)
Rank #26 of 364Beats 92% of peers
Bumpiness (3Y)
13.40%median 15.58% (-2.18%)
Rank #60 of 364Less risky than 83% of peers
Worst-ever drop
-15.68%median -25.21% (+9.53%)
Rank #300 of 364Less risky than 17% of peers

Descriptive rankings within the same category and plan. Not a recommendation — one fund beating another historically does not mean it will continue to do so.

Year by year

Calendar-year returns. 2 of last 3 years were positive.

+0%
2024
-3%
2025
+24%
2026
Best year
2026 · 23.86%
Worst year
2025 · -2.96%

Price over time

How the per-unit price has moved. Tap a range to zoom in.

Bumpiness & worst drops

Day-to-day bumpiness
13.4%

The value swings roughly 13% up or down in a typical year. Finance-speak calls this volatility.

Worst drop ever
-15.68%

A lump sum invested at the previous peak would have temporarily lost about this much before recovering. Finance-speak calls this max drawdown.

Similar funds you might want to look at

Same category, same plan, sorted by 3-year return. Not recommendations — just neighbours.

Head-to-head comparisons

Side-by-side comparisons of Bajaj Finserv Healthcare Fund - Direct Plan - Growth against other sector funds.

Technical details (for the pros)
CAGR — 1 year22.00%
CAGR — 3 years—
CAGR — 5 years—
CAGR — since launch11.68%
Volatility — 1 year (annualised)12.35%
Volatility — 3 years (annualised)13.40%
Max drawdown — 1 year-10.07%
Max drawdown — 3 years-15.68%
Sharpe ratio — 1 year (rf=6%)1.16
Sharpe ratio — 3 years (rf=6%)0.39

Fund info

Fund house
Bajaj Finserv Mutual Fund
Category
Equity Scheme - Sectoral/ Thematic
Plan
Direct
Option
Growth
ISIN (Growth)
INF0QA701AB9
ISIN (Div re-invest)
—
Fund code
153157
First price on record
30 Dec 2024 · 417 daily prices

About Bajaj Finserv Healthcare Fund - Direct Plan - Growth

Bajaj Finserv Healthcare Fund - Direct Plan - Growth is a Equity Scheme - Sectoral/ Thematic offered by Bajaj Finserv Mutual Fund under the Direct plan with the Growth option. It has approximately 2 year of NAV track record. The fund falls in the sector category — Invests only in one industry or theme (like banking, pharma, tech). Highly concentrated — bigger swings.

The current NAV of Bajaj Finserv Healthcare Fund - Direct Plan - Growth is ₹12.1350 (as of 4 Sep 2026). Historically, it has delivered 21.98% over the last year. Returns are historical and don't predict future performance.

Over the last three years, the fund's prices have moved with 13.4% annualised volatility — a "high" level of bumpiness; its deepest peak-to-trough fall on record was 15.7%. Being mentally prepared for drawdowns of this size is what separates long-term investors from reactive traders.

Frequently asked

What is the latest NAV of Bajaj Finserv Healthcare Fund - Direct Plan - Growth?+

The latest NAV of Bajaj Finserv Healthcare Fund - Direct Plan - Growth is ₹12.1350 as of 4 Sep 2026, down 0.48% from the previous day. NAV is updated once a business day after the market close.

What are the returns of Bajaj Finserv Healthcare Fund - Direct Plan - Growth?+

Bajaj Finserv Healthcare Fund - Direct Plan - Growth has delivered 1-year return 21.98%, since-inception CAGR 11.68%. Returns are historical and don't predict future performance — markets move in cycles.

What category does Bajaj Finserv Healthcare Fund - Direct Plan - Growth belong to?+

Bajaj Finserv Healthcare Fund - Direct Plan - Growth is categorised as Equity Scheme - Sectoral/ Thematic. Invests only in one industry or theme (like banking, pharma, tech). Highly concentrated — bigger swings.

How risky is Bajaj Finserv Healthcare Fund - Direct Plan - Growth?+

Based on its 3-year annualised volatility of 13.4%, Bajaj Finserv Healthcare Fund - Direct Plan - Growth sits in the "high" risk bucket. Volatility measures how much prices swing — higher means bigger ups and downs along the way.

Is Bajaj Finserv Healthcare Fund - Direct Plan - Growth a direct plan?+

Bajaj Finserv Healthcare Fund - Direct Plan - Growth is a Direct plan (no distributor commission — lower expense ratio) with the Growth option (all returns compound within the fund, no interim payouts).

How old is Bajaj Finserv Healthcare Fund - Direct Plan - Growth?+

Bajaj Finserv Healthcare Fund - Direct Plan - Growth has NAV history available from 30 Dec 2024 — approximately 2 year of track record and 417 daily NAV observations.

Numbers are computed from stored daily prices from mfapi.in/AMFI. This is descriptive analytics, not investment advice. Past performance is not indicative of future returns.